While diabetes leads to myocardial structural and function abnormalities in vivo, administration of GLP-1 analog, LIRA, improved the disorder of cardiac muscle fibers and LV diastolic and systolic parameters. The gene discussed is GLP1R; the disease is diabetes mellitus.